UTI · Antibiotic comparison

Macrobid vs Cephalexin for a UTI?

Two antibiotics, two very different drug families. Here is how nitrofurantoin (Macrobid) and cephalexin actually compare on spectrum, dosing, safety, and pregnancy, and how a clinician decides which one fits a given person.

How do Macrobid and cephalexin differ in spectrum and how they work?

The biggest difference is where each drug does its job. Nitrofurantoin is a nitrofuran that is filtered into the urine and reaches very high concentrations inside the bladder. That makes it well suited to a simple bladder infection (cystitis), where most cases are caused by E. coli. The flip side is that nitrofurantoin does not reach meaningful levels in blood or kidney tissue, so it is not used to treat a kidney infection (pyelonephritis) or any infection that has spread beyond the bladder.

Cephalexin is a first-generation cephalosporin, which is a beta-lactam in the same broad family as penicillins. It is absorbed and reaches systemic levels, covering many gram-positive organisms and some gram-negative urinary bugs. Because it works throughout the body rather than just in urine, it has different uses and a different resistance profile. Local resistance among common urinary E. coli can be meaningfully higher for some beta-lactams than for nitrofurantoin, which is one reason guidelines tend to favor nitrofurantoin first when it is appropriate.

When do clinicians choose cephalexin instead of Macrobid for a UTI?

Culture susceptibility, allergy history, prior reactions and renal function can make cephalexin an option when nitrofurantoin is unsuitable. Cephalexin also needs renal dose assessment, and prior serious penicillin or cephalosporin reactions matter. Neither a kidney problem nor a drug allergy automatically identifies the correct substitute.

None of this means cephalexin is the stronger drug. It means the two are tools for different jobs, and matching the tool to the patient is the whole point. This is exactly the kind of judgment described in our clinical protocols, which favor narrow, guideline-concordant agents when they fit and reserve broader drugs for when they are truly needed.

Can Macrobid or cephalexin be used during pregnancy for a UTI?

Both may be used for a bladder infection in pregnancy after obstetric assessment. ACOG considers nitrofurantoin reasonable in the first trimester when no appropriate alternative is available and advises avoiding it in people with G6PD deficiency; the Macrobid label contraindicates it at term (38 to 42 weeks), during labor and delivery, or when labor is imminent. Pregnancy requires urine culture and appropriate follow-up. Bidwell does not treat UTI during pregnancy.

What does a clinician weigh when choosing a UTI antibiotic?

Behind a seemingly simple prescription is a short checklist. Is this an uncomplicated bladder infection or something more serious like a kidney infection? What is the person's kidney function? Are they pregnant? Any allergies or prior reactions? Do earlier culture results or local resistance patterns point one way? Are there drug interactions, and what is the cost and pill burden? Finally, stewardship: guidelines, including IDSA's archived 2010 guideline and EAU 2026, favor narrow agents like nitrofurantoin first when they fit, to slow the spread of resistance. A good prescriber balances all of these rather than defaulting to whatever is most familiar.

When is Bidwell Health appropriate, and when is it not?

Bidwell Health is a cash-pay ($45 visit fee; medication separate) online care practice. Its routine UTI service is for eligible nonpregnant adult women ages 18 and older in 11 states (Arizona, Colorado, Connecticut, Florida, Iowa, Maryland, Montana, New Mexico, Utah, Virginia, and Washington). It can be a good fit for a straightforward, uncomplicated bladder infection in an otherwise healthy nonpregnant adult woman, where a provider reviews your history and symptoms and, when clinically appropriate, sends treatment to your pharmacy. You can read more about online UTI treatment and what the visit covers.

Bidwell’s routine online UTI pathway is for eligible nonpregnant adult women ages 18 and older in our 11 supported states. Men, children, pregnancy, suspected kidney infection and complicated infections need a different care setting. Recurrent UTIs (two or more in six months, or three or more in twelve months) are outside Bidwell's routine online visit and need in-person assessment with a urine culture. A failed antibiotic course does not automatically rule out online review; the clinician reassesses symptoms and testing needs before choosing further treatment. Being over 65 alone is not an automatic exclusion; individual symptoms, health history and testing needs determine suitability. Seek same-day in-person care for fever of 100.4°F (38°C) or higher, chills, pain in the side or back below the ribs, severe pelvic or lower abdominal pain, vomiting, visible blood in the urine without typical bladder-infection symptoms, heavy bleeding or clots, or blood that persists after treatment. Get same-day care if urinary symptoms get worse quickly or significantly. If pregnant or possibly pregnant, contact your obstetric clinician promptly. Call 911 or go to the emergency department for confusion, fainting, trouble breathing, inability to stay awake, or severe illness; inability to urinate or inability to keep fluids down also needs urgent emergency assessment. Do not wait for an online review. The visit fee is $45; medications are paid separately, and a prescription is not guaranteed.